Diagnostic Assays for Identification of Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer

In series dominated by adenocarcinoma histology, approximately 5% of non–small cell lung cancers (NSCLCs) harbor an anaplastic lymphoma kinase (ALK) gene rearrangement. Crizotinib, a tyrosine kinase inhibitor with significant activity against ALK, has demonstrated high response rates and prolonged p...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Weickhardt, Andrew J., Aisner, Dara L., Franklin, Wilbur A., Varella-Garcia, Marileila, Doebele, Robert C., Camidge, D. Ross
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3935240/
https://ncbi.nlm.nih.gov/pubmed/23280244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.27913
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares